安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- Denosumab - Wikipedia
Denosumab, sold under the brand name Prolia among others, is a human monoclonal antibody used for the treatment of osteoporosis, treatment-induced bone loss, metastases to bone, and giant cell tumor of bone
- Denosumab (subcutaneous route) - Mayo Clinic
It is used to prevent bone problems in patients with multiple myeloma and bone metastases (cancer that has spread) from tumors Denosumab is also used to treat giant cell tumor of the bone that cannot be removed by surgery
- Denosumab - StatPearls - NCBI Bookshelf
Denosumab is a bone anti-resorptive drug used for the treatment of the following: Prevention of skeletal-related events: Denosumab is indicated for bone pain and fractures secondary to multiple myeloma or bone metastases from solid tumors Used in conjunction with treatments for primary malignancy [1]
- Prolia Injection (Denosumab): Uses Side Effects - Cleveland Clinic
DENOSUMAB (den oh sue mab) slows bone breakdown Prolia is used to treat osteoporosis in women after menopause and in men, and in people who are taking corticosteroids for 6 months or more
- Prolia (Prolia, Jubbonti, Wyost) - Uses, Side Effects, and More
Denosumab (Prolia, Jubbonti, Wyost) is commonly used to treat osteoporosis, a condition in which the bones are thinner, weaker, and more prone to breakage Denosumab may be prescribed for
- Denosumab Injection: MedlinePlus Drug Information
Denosumab injection products come as a solution (liquid) to be injected subcutaneously (under the skin) in your upper arm, upper thigh, or stomach area It is usually injected by a doctor or nurse in a medical office or clinic
- Denosumab: Bone Loss Uses, Side Effects, Warnings, Dosage - MedicineNet
Denosumab is a lab-made human monoclonal immunoglobulin G2 (IgG2) antibody medication used to reduce bone loss in patients at high risk for bone fractures due to postmenopausal osteoporosis, cancers or other conditions
- Denosumab (Xgeva®, Prolia®) - Macmillan Cancer Support
Denosumab (XGEVA®, Prolia®) is used to strengthen and protect the bones from the effect of cancer or cancer treatment It belongs to a group of targeted therapy drugs known as monoclonal antibodies
|
|
|